• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于证据的医学时代中的激光。

Lasers in the era of evidence-based medicine.

机构信息

Department of Obstetrics and Gynaecology, University Hospitals Dorset, Poole, UK.

出版信息

Climacteric. 2020;23(sup1):S6-S10. doi: 10.1080/13697137.2020.1774536.

DOI:10.1080/13697137.2020.1774536
PMID:33124459
Abstract

Transvaginal laser therapies are being increasingly used for a variety of indications, particularly genitourinary syndrome of the menopause and stress urinary incontinence. This article reviews the current data pertaining to the place of these devices in current clinical practice. Whilst there has been a rapid increase in the number of publications over the last few years, many of the studies are of small numbers, short duration, and poor quality and are device-sponsored. The evidence suggests that vaginal laser therapy with either the erbium-doped yttrium aluminum garnet laser (FotonaSmooth) or the CO laser (MonaLisa Touch) is an effective intervention for the relief of symptoms of vulvovaginal atrophy in symptomatic women. The benefits of three laser treatments appear to last for at least 12 months and the procedure is generally well tolerated, with transient minor discomfort being the most common adverse event. Whilst the vaginal laser certainly has the potential to be an alternative treatment to vaginal estrogens for those groups of women, such as breast cancer patients, who cannot take them, there are still many unanswered questions about the role of vaginal laser therapy in clinical practice, particularly in relation to standard conservative management. The place of vaginal laser therapy in other conditions such as stress urinary incontinence is less clear. The outcomes from several ongoing randomized trials should help to answer some of these questions. In the meantime, the use of vaginal laser devices should be confined to clinical trials.

摘要

经阴道激光治疗因其广泛的适应证而被日益应用,尤其是在女性生殖泌尿道综合征和压力性尿失禁方面。本文回顾了这些设备在目前临床实践中的应用的相关数据。尽管在过去几年中,相关出版物的数量迅速增加,但许多研究的样本量较小、持续时间较短且质量较差,并且这些研究都得到了设备制造商的赞助。有证据表明,铒石榴石激光(FotonaSmooth)或 CO2 激光(MonaLisa Touch)阴道激光治疗对于缓解有症状的女性的阴道萎缩症状是一种有效的干预措施。三次激光治疗的益处似乎至少持续 12 个月,并且该程序通常具有良好的耐受性,最常见的不良反应是短暂的轻微不适。虽然阴道激光对于那些不能使用阴道雌激素的女性(如乳腺癌患者)来说,确实有可能成为阴道雌激素治疗的替代方法,但关于阴道激光治疗在临床实践中的作用,特别是在标准保守治疗方面,仍有许多未解决的问题。阴道激光治疗在其他疾病中的作用,如压力性尿失禁,还不太明确。几项正在进行的随机试验的结果将有助于回答其中的一些问题。同时,阴道激光设备的使用应仅限于临床试验。

相似文献

1
Lasers in the era of evidence-based medicine.基于证据的医学时代中的激光。
Climacteric. 2020;23(sup1):S6-S10. doi: 10.1080/13697137.2020.1774536.
2
No. 358-Intravaginal Laser for Genitourinary Syndrome of Menopause and Stress Urinary Incontinence.第358号——阴道内激光治疗更年期泌尿生殖综合征和压力性尿失禁
J Obstet Gynaecol Can. 2018 Apr;40(4):503-511. doi: 10.1016/j.jogc.2017.11.040.
3
Laser Therapy for Genitourinary Syndrome of Menopause.激光治疗更年期泌尿生殖综合征
Curr Urol Rep. 2018 Aug 17;19(10):83. doi: 10.1007/s11934-018-0831-y.
4
Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.阴道铒激光治疗绝经后泌尿生殖综合征的长期效果
Climacteric. 2018 Apr;21(2):148-152. doi: 10.1080/13697137.2018.1436538. Epub 2018 Feb 13.
5
Rationale and design for fractional microablative CO laser versus photothermal non-ablative erbium:YAG laser for the management of genitourinary syndrome of menopause: a non-inferiority, single-blind randomized controlled trial.分微剥脱 CO2 激光与光热非剥脱铒:YAG 激光治疗女性泌尿生殖系统绝经综合征的原理和设计:一项非劣效性、单盲、随机对照试验。
Climacteric. 2019 Jun;22(3):307-311. doi: 10.1080/13697137.2018.1559806. Epub 2019 Jan 24.
6
A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.一项比较阴道激光治疗与阴道雌激素治疗女性绝经后泌尿生殖系统综合征的随机临床试验:VeLVET 试验。
Menopause. 2020 Jan;27(1):50-56. doi: 10.1097/GME.0000000000001416.
7
IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity.国际尿控学会委员会意见:用于治疗压力性尿失禁、绝经后泌尿生殖综合征及阴道松弛的激光阴道治疗设备
Int Urogynecol J. 2019 Mar;30(3):371-376. doi: 10.1007/s00192-018-3830-0. Epub 2018 Dec 6.
8
Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.阴道激光治疗 GSM/VVA:我们现在的立场——EUGA 激光工作组的综述。
Climacteric. 2023 Aug;26(4):336-352. doi: 10.1080/13697137.2023.2225766. Epub 2023 Jul 3.
9
The evidence behind the use of LASER for genitourinary syndrome of menopause, vulvovaginal atrophy, urinary incontinence and lichen sclerosus: A state-of-the-art review.激光治疗女性生殖泌尿综合征(绝经后外阴阴道萎缩、尿失禁和硬化性苔藓)的证据:最新综述。
Acta Obstet Gynecol Scand. 2022 Jun;101(6):657-692. doi: 10.1111/aogs.14353. Epub 2022 Apr 28.
10
Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.阴道铒激光学会研究(VELAS)的原理与设计:一项关于绝经后泌尿生殖综合征和压力性尿失禁的国际多中心观察性研究。
Climacteric. 2015;18 Suppl 1:43-8. doi: 10.3109/13697137.2015.1071608.

引用本文的文献

1
Fractional CO Laser, Radiofrequency and Topical Estrogen for Treating Genitourinary Syndrome of Menopause: A Pilot Study Evaluating the Vulvar Vestibule.CO2 激光、射频和局部雌激素治疗女性泌尿生殖系统绝经综合征:评估外阴前庭的初步研究。
Medicina (Kaunas). 2023 Dec 30;60(1):80. doi: 10.3390/medicina60010080.
2
Genitourinary Syndrome of Menopause in Breast Cancer Survivors: Current Perspectives on the Role of Laser Therapy.乳腺癌幸存者的绝经后泌尿生殖综合征:激光治疗作用的当前观点
Int J Womens Health. 2023 Aug 8;15:1261-1282. doi: 10.2147/IJWH.S414509. eCollection 2023.
3
Managing female sexual dysfunction.
女性性功能障碍管理。
Urol Oncol. 2022 Aug;40(8):359-365. doi: 10.1016/j.urolonc.2021.06.006. Epub 2021 Jul 8.